CORRESP

November 30, 2020

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

 

Attention:

Suzanne Hayes

    

Jeff Gabor

    

Sasha Parikh

    

Tracey Houser

Re:

Outset Medical, Inc.

    

Registration Statement on Form S-1

    

File No. 333-251031

Acceleration Request

 

  Requested Date:

December 2, 2020

  Requested Time:

4:00 P.M., Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Outset Medical, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1, Registration Number 333-251031 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 P.M. Eastern Time, on December 2, 2020, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.

We would appreciated it if, as soon as the Registration Statement is declared effective, you would so inform Robert A. Ryan of Sidley Austin LLP at (212) 839-5931.

 

Very truly yours,
/s/ John L. Brottem
John L. Brottem
General Counsel
Outset Medical, Inc.

 

cc:

Leslie Trigg, President, Chief Executive Officer and Director

    

Rebecca Chambers, Chief Financial Officer

    

Frank F. Rahmani, Sidley Austin LLP

    

Robert A. Ryan, Sidley Austin LLP

    

Helen Theung, Sidley Austin LLP

    

Nathan Ajiashvili, Latham & Watkins LLP

    

Brian Cuneo, Latham & Watkins LLP

    

Salvatore Vanchieri Jr., Latham & Watkins LLP